FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119785087> ?p ?o ?g. }

• W2119785087 endingPage "2975" @default.
• W2119785087 startingPage "2967" @default.
• W2119785087 abstract "Abstract Appropriate presentation of tumor-associated antigens (TAA) by antigen-presenting cells (APC) is required for the development of clinically relevant antitumor T-cell responses. One common approach, which uses APC pulsed with synthetic peptides, can sometimes generate ineffective immune responses. This failure may, in part, be attributed to the formation of HLA/synthetic pulsed peptide complexes that possess different conformations compared with those of endogenously presented peptides. In addition, endogenous peptides may undergo post-translational modifications, which do not occur with synthetic peptides. Because our goal is to induce immunity that can recognize TAA that are endogenously presented by tumors, we designed an APC that would not only express the required immunoaccessory molecules but also naturally process and present target antigenic peptides. In this study, we generated an artificial APC (aAPC) that can endogenously present any chosen HLA-A*0201 (A2)–restricted peptide by processing a fusion protein that contains a unique “LTK” sequence linked to the antigenic peptide. Proteasome-dependent processing is so effective that the presented peptide can be directly eluted from the cell surface and identified by biochemical methods. Furthermore, we found that aAPC, engineered to endogenously present peptide derived from the melanoma antigen MART1, can be used to prime and expand antitumor CTL that target MART1-expressing tumor cells in a HLA-A2-restricted manner. Our engineered aAPC could serve as an “off-the-shelf” APC designed to constitutively express class I–restricted TAA peptides and could be used to generate effective T-cell responses to treat human disease." @default.
• W2119785087 created "2016-06-24" @default.
• W2119785087 creator A5008158683 @default.
• W2119785087 creator A5011010076 @default.
• W2119785087 creator A5019128517 @default.
• W2119785087 creator A5024678664 @default.
• W2119785087 creator A5032640587 @default.
• W2119785087 creator A5058104480 @default.
• W2119785087 creator A5088433231 @default.
• W2119785087 date "2006-05-15" @default.
• W2119785087 modified "2023-10-16" @default.
• W2119785087 title "Efficient Presentation of Naturally Processed HLA Class I Peptides by Artificial Antigen-Presenting Cells for the Generation of Effective Antitumor Responses" @default.
• W2119785087 cites W1503805720 @default.
• W2119785087 cites W1504394780 @default.
• W2119785087 cites W1509731174 @default.
• W2119785087 cites W1527289043 @default.
• W2119785087 cites W1558740094 @default.
• W2119785087 cites W1939839386 @default.
• W2119785087 cites W1967425011 @default.
• W2119785087 cites W1970219838 @default.
• W2119785087 cites W1970788875 @default.
• W2119785087 cites W1971302107 @default.
• W2119785087 cites W1983928444 @default.
• W2119785087 cites W1984678830 @default.
• W2119785087 cites W1989660541 @default.
• W2119785087 cites W1990395260 @default.
• W2119785087 cites W1991385476 @default.
• W2119785087 cites W1992275362 @default.
• W2119785087 cites W1992699637 @default.
• W2119785087 cites W1994793713 @default.
• W2119785087 cites W2021242983 @default.
• W2119785087 cites W2032203698 @default.
• W2119785087 cites W2034244225 @default.
• W2119785087 cites W2036150733 @default.
• W2119785087 cites W2057417956 @default.
• W2119785087 cites W2059092169 @default.
• W2119785087 cites W2063434032 @default.
• W2119785087 cites W2064718707 @default.
• W2119785087 cites W2068167262 @default.
• W2119785087 cites W2070434454 @default.
• W2119785087 cites W2071708791 @default.
• W2119785087 cites W2077521424 @default.
• W2119785087 cites W2079766756 @default.
• W2119785087 cites W2087137589 @default.
• W2119785087 cites W2089892946 @default.
• W2119785087 cites W2092162393 @default.
• W2119785087 cites W2116198725 @default.
• W2119785087 cites W2116553226 @default.
• W2119785087 cites W2137074525 @default.
• W2119785087 cites W2140758955 @default.
• W2119785087 cites W2143935255 @default.
• W2119785087 cites W2148523692 @default.
• W2119785087 cites W2151246207 @default.
• W2119785087 cites W2158164086 @default.
• W2119785087 cites W2163357710 @default.
• W2119785087 doi "https://doi.org/10.1158/1078-0432.ccr-05-2791" @default.
• W2119785087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16707591" @default.
• W2119785087 hasPublicationYear "2006" @default.
• W2119785087 type Work @default.
• W2119785087 sameAs 2119785087 @default.
• W2119785087 citedByCount "35" @default.
• W2119785087 countsByYear W21197850872012 @default.
• W2119785087 countsByYear W21197850872013 @default.
• W2119785087 countsByYear W21197850872014 @default.
• W2119785087 countsByYear W21197850872015 @default.
• W2119785087 countsByYear W21197850872016 @default.
• W2119785087 countsByYear W21197850872017 @default.
• W2119785087 countsByYear W21197850872020 @default.
• W2119785087 countsByYear W21197850872021 @default.
• W2119785087 countsByYear W21197850872022 @default.
• W2119785087 crossrefType "journal-article" @default.
• W2119785087 hasAuthorship W2119785087A5008158683 @default.
• W2119785087 hasAuthorship W2119785087A5011010076 @default.
• W2119785087 hasAuthorship W2119785087A5019128517 @default.
• W2119785087 hasAuthorship W2119785087A5024678664 @default.
• W2119785087 hasAuthorship W2119785087A5032640587 @default.
• W2119785087 hasAuthorship W2119785087A5058104480 @default.
• W2119785087 hasAuthorship W2119785087A5088433231 @default.
• W2119785087 hasBestOaLocation W21197850871 @default.
• W2119785087 hasConcept C108249834 @default.
• W2119785087 hasConcept C147483822 @default.
• W2119785087 hasConcept C147969180 @default.
• W2119785087 hasConcept C167672396 @default.
• W2119785087 hasConcept C188280979 @default.
• W2119785087 hasConcept C195616568 @default.
• W2119785087 hasConcept C203014093 @default.
• W2119785087 hasConcept C2776090121 @default.
• W2119785087 hasConcept C2777701055 @default.
• W2119785087 hasConcept C2779281246 @default.
• W2119785087 hasConcept C502942594 @default.
• W2119785087 hasConcept C55493867 @default.
• W2119785087 hasConcept C67662055 @default.
• W2119785087 hasConcept C70721500 @default.
• W2119785087 hasConcept C83464605 @default.
• W2119785087 hasConcept C86803240 @default.
• W2119785087 hasConcept C8891405 @default.
• W2119785087 hasConcept C95444343 @default.
• W2119785087 hasConceptScore W2119785087C108249834 @default.

• next